Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

Trump White House Logs Document Drug Industry Visitors, Meetings

By Caroline Chen

X
Your article was successfully shared with the contacts you provided.

Drug company executives were among the many visitors to the White House complex this year, according to visitor logs published Tuesday by ProPublica after a nonprofit transparency group, Property of the People, successfully sued the Trump administration to release the records.

From Jan. 20 to Sept. 6, several health executives paid visits. At the Office of Management and Budget, Director Mick Mulvaney was listed as meeting with:

  • Heather Bresch, CEO of Mylan Dan Gallagher, chief legal officer of Mylan (twice).

  • Larry Merlo, CEO of CVS Health Corp.

  • Stephen Hemsley, chairman of UnitedHealth Group Inc.

  • Patrick Soon-Shiong, billionaire health entrepreneur and CEO of NantHealth Inc.

  • The board of directors from industry group Pharmaceutical Research and Manufacturers of America (PhRMA).

Mulvaney’s calendar also lists a “meeting: drug pricing” on June 1 and another “drug pricing meeting prep” on June 12.

At the Office of the U.S. Trade Representative, health care visitors included meetings with representatives from PhRMA and Biotechnology Innovation Organization (BIO):

  • Stephen Ubl, CEO of PhRMA.

  • Andy Hartsfield, head of U.S. government relations at Sanofi.

  • Jennifer Young, director of international policy at Pfizer Inc.

  • Laurie Hueneke, executive director of animal health public policy & government relations at Merck & Co.

  • David Kavanaugh, director of federal affairs at Johnson & Johnson.

—Read Trump Meets With Democrats at White House on Drug Prices on ThinkAdvisor.


— Connect with ThinkAdvisor Life/Health on Facebook and Twitter.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.